State Street
CABA icon

State Street’s Cabaletta Bio CABA Stock Holding History

State Street’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.4M Buy
7,839,305
+7,369,327
+1,568% +$24.2M ﹤0.01% 2252
2026
Q1 		$1.26M Buy
469,978
+44,500
+10% +$124K ﹤0.01% 3432
2025
Q4 		$932K Buy
425,478
+48,678
+13% +$121K ﹤0.01% 3538
2025
Q3 		$882K Buy
376,800
+158,833
+73% +$273K ﹤0.01% 3540
2025
Q2 		$331K Sell
217,967
-720,751
-77% -$1.12M ﹤0.01% 3708
2025
Q1 		$1.3M Buy
938,718
+740
+0.1% +$1.58K ﹤0.01% 3376
2024
Q4 		$2.13M Buy
937,978
+41,855
+5% +$147K ﹤0.01% 3299
2024
Q3 		$4.23M Sell
896,123
-1,109,678
-55% -$6.42M ﹤0.01% 3042
2024
Q2 		$15M Sell
2,005,801
-1,735,659
-46% -$21.3M ﹤0.01% 2314
2024
Q1 		$63.8M Buy
3,741,460
+1,146,990
+44% +$24.6M ﹤0.01% 1592
2023
Q4 		$58.9M Buy
2,594,470
+1,061,628
+69% +$17.8M ﹤0.01% 1620
2023
Q3 		$23.3M Buy
1,532,842
+1,071,345
+232% +$14.6M ﹤0.01% 2070
2023
Q2 		$5.96M Buy
461,497
+379,030
+460% +$4.11M ﹤0.01% 2912
2023
Q1 		$682K Sell
82,467
-5,200
-6% -$48.7K ﹤0.01% 3646
2022
Q4 		$811K Buy
87,667
+26,800
+44% +$97.6K ﹤0.01% 3612
2022
Q3 		$40K Hold
60,867
– – ﹤0.01% 4702
2022
Q2 		$65K Buy
60,867
+2,100
+4% +$2.97K ﹤0.01% 4665
2022
Q1 		$119K Buy
58,767
+2,760
+5% +$7.22K ﹤0.01% 4590
2021
Q4 		$212K Buy
56,007
+14,000
+33% +$149K ﹤0.01% 4323
2021
Q3 		$511K Buy
42,007
+19,200
+84% +$177K ﹤0.01% 3968
2021
Q2 		$196K Sell
22,807
-181,509
-89% -$1.78M ﹤0.01% 4217
2021
Q1 		$2.27M Buy
204,316
+4,685
+2% +$57.2K ﹤0.01% 3390
2020
Q4 		$2.49M Buy
199,631
+36,917
+23% +$479K ﹤0.01% 3274
2020
Q3 		$1.76M Buy
162,714
+29,222
+22% +$336K ﹤0.01% 3247
2020
Q2 		$1.49M Buy
133,492
+28,093
+27% +$215K ﹤0.01% 3296
2020
Q1 		$769K Buy
105,399
+60,085
+133% +$824K ﹤0.01% 3368
2019
Q4 		$633K Buy
+45,314
New +$537K ﹤0.01% 3487

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street's CABA Position: Q2 2026 in Review

State Street increased its Cabaletta Bio (CABA) stake by 1,568% in Q2 2026, buying an estimated $24.2M and bringing the position to 7,839,305 shares worth $24.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2252.

State Street first reported a position in CABA in Q4 2019 and has held it in 27 quarters since. The position peaked at $63.8M in Q1 2024. 86 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • State Street held 7,839,305 shares of Cabaletta Bio worth $24.4M as of Q2 2026.
  • State Street bought 7,369,327 Cabaletta Bio shares in Q2 2026, an estimated $24.2M.
  • Cabaletta Bio made up ﹤0.01% of State Street's portfolio in Q2 2026, its #2252 holding.
  • State Street first reported a position in Cabaletta Bio in Q4 2019 and has held it in 27 quarters since.
  • State Street's Cabaletta Bio position peaked at $63.8M in Q1 2024.
  • 86 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.